Enlivex Therapeutics Ltd.
ENLV
$1.05
-$0.05-4.55%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.12% | -5.54% | 10.69% | -14.22% | -10.42% |
| Total Receivables | 1.14% | 11.12% | -65.99% | 1,516.59% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -9.70% | -14.20% | 27.34% | -19.06% | -10.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -13.16% | 0.00% | -33.33% | -93.30% | 4,420.35% |
| Total Current Assets | -4.12% | -5.11% | 0.68% | -15.96% | 6.04% |
|
|
|||||
| Total Current Assets | -4.12% | -5.11% | 0.68% | -15.96% | 6.04% |
| Net Property, Plant & Equipment | -34.90% | -12.67% | -9.55% | -13.10% | -81.96% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -40.87% | -29.83% | 203.96% | -11.91% | -38.82% |
| Total Assets | -7.08% | -6.60% | 2.75% | -15.70% | -21.53% |
|
|
|||||
| Total Accounts Payable | 781.52% | -69.64% | -52.88% | -22.25% | 4.16% |
| Total Accrued Expenses | 10.96% | 6.86% | -16.11% | -28.18% | 28.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -32.08% | 2.98% | -1.47% | -1.45% | -50.64% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 36.12% | -1.76% | -21.28% | -40.46% | 39.69% |
|
|
|||||
| Total Current Liabilities | 36.12% | -1.76% | -21.28% | -40.46% | 39.69% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -28.64% | -16.03% | -14.99% | -14.43% | -82.03% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 27.66% | -3.89% | -20.40% | -37.81% | -17.29% |
|
|
|||||
| Common Stock & APIC | 1.48% | 0.43% | 3.39% | 0.64% | 0.28% |
| Retained Earnings | -4.25% | -2.18% | -2.66% | -3.69% | -8.83% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Common Equity | -11.28% | -6.91% | 6.37% | -10.75% | -22.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.28% | -6.91% | 6.37% | -10.75% | -22.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.28% | -6.91% | 6.37% | -10.75% | -22.42% |
|
|
|||||